Literature DB >> 15195318

Analysis of pilot and early phase studies with small sample sizes.

Weichung Joseph Shih1, Pamela A Ohman-Strickland, Yong Lin.   

Abstract

The need for statistical methodologies for analysing a small size study, such as a pilot or so-called 'proof of concept' study, has not been paid much attention in the past. Recently the Institute of Medicine (IOM) formed a committee and held a workshop to discuss methodologies for conducting clinical trials with small number participants. In this paper we argue that the hypothesis of treatment effect in a small pilot study should be set up to test whether any individual subject has an effect rather than whether the group mean or median has shifted as often done for large, confirmatory clinical trials. Based on this paradigm we propose multiple test procedures as one option when individuals have enough observations, and a mixture-distribution approach when individuals have one or more observations. The latter approach may be used in either a one- or two-group setting, and is our focus in this paper. We present the likelihood ratio tests for the mixture models. Examples are given to demonstrate the methods. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15195318     DOI: 10.1002/sim.1807

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  19 in total

1.  Attention to Individuals: Mixed Methods for N-of-1 Health Care Interventions.

Authors:  Peter H Van Ness; Terrence E Murphy; Ather Ali
Journal:  J Mix Methods Res       Date:  2016-01-11

2.  Improvement in resiliency factors among adolescents with neurofibromatosis who participate in a virtual mind-body group program.

Authors:  Ethan G Lester; Eric A Macklin; Scott Plotkin; Ana-Maria Vranceanu
Journal:  J Neurooncol       Date:  2020-02-20       Impact factor: 4.130

3.  The impact of a mind-body program on multiple dimensions of resiliency among geographically diverse patients with neurofibromatosis.

Authors:  Emily L Zale; Catherine Pierre-Louis; Eric A Macklin; Eric Riklin; Ana-Maria Vranceanu
Journal:  J Neurooncol       Date:  2017-12-23       Impact factor: 4.130

4.  Power matters in closing the phenotyping gap.

Authors:  Carola W Meyer; Ralf Elvert; André Scherag; Nicole Ehrhardt; Valerie Gailus-Durner; Helmut Fuchs; Helmut Schäfer; Martin Hrabé de Angelis; Gerhard Heldmaier; Martin Klingenspor
Journal:  Naturwissenschaften       Date:  2007-01-10

5.  First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial.

Authors:  Christopher J Funes; Ryan A Mace; Erik A Macklin; Scott R Plotkin; Justin T Jordan; Ana-Maria Vranceanu
Journal:  J Neurooncol       Date:  2019-05-02       Impact factor: 4.130

6.  TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study.

Authors:  Edward Tobinick; Hyman Gross; Alan Weinberger; Hart Cohen
Journal:  MedGenMed       Date:  2006-04-26

7.  A two-stage phase II clinical trial design with nested criteria for early stopping and efficacy.

Authors:  Michelle DeVeaux; Michael Kane; Wei Wei; Daniel Zelterman
Journal:  Pharm Stat       Date:  2019-09-10       Impact factor: 1.894

8.  Mixed Methods for the Interpretation of Longitudinal Gerontologic Data: Insights From Philosophical Hermeneutics.

Authors:  Peter H Van Ness; Terri R Fried; Thomas M Gill
Journal:  J Mix Methods Res       Date:  2011-07-13

9.  Cultivating resiliency in patients with neurofibromatosis 2 who are deafened or have severe hearing loss: a live‑video randomized control trial.

Authors:  Jonathan Greenberg; Sarah Carter; Ethan Lester; Christopher J Funes; Eric A Macklin; Scott Plotkin; Ana-Maria Vranceanu
Journal:  J Neurooncol       Date:  2019-11-01       Impact factor: 4.130

10.  Creative Music Therapy and Neurodevelopmental Outcomes in Pre-term Infants at 2 Years: A Randomized Controlled Pilot Trial.

Authors:  Friederike Barbara Haslbeck; Hans Ulrich Bucher; Dirk Bassler; Cornelia Hagmann; Giancarlo Natalucci
Journal:  Front Pediatr       Date:  2021-06-18       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.